Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$241K Hold
1,667
0.04% 75
2025
Q2
$211K Hold
1,667
0.04% 75
2025
Q1
$213K Sell
1,667
-77
-4% -$10.4K 0.04% 77
2024
Q4
$231K Hold
1,744
0.04% 76
2024
Q3
$254K Hold
1,744
0.05% 72
2024
Q2
$239K Hold
1,744
0.05% 67
2024
Q1
$239K Hold
1,744
0.05% 69
2023
Q4
$237K Sell
1,744
-22
-1% -$2.68K 0.05% 64
2023
Q3
$216K Hold
1,766
0.05% 67
2023
Q2
$224K Hold
1,766
0.05% 70
2023
Q1
$228K Hold
1,766
0.06% 71
2022
Q4
$232K Sell
1,766
-496
-22% -$64.1K 0.06% 67
2022
Q3
$269K Sell
2,262
-1
-0% -$124 0.09% 57
2022
Q2
$266K Hold
2,263
0.09% 62
2022
Q1
$295K Hold
2,263
0.09% 64
2021
Q4
$345K Hold
2,263
0.11% 59
2021
Q3
$366K Hold
2,263
0.12% 57
2021
Q2
$370K Sell
2,263
-45
-2% -$6.93K 0.13% 57
2021
Q1
$348K Buy
2,308
+46
+2% +$7.31K 0.14% 56
2020
Q4
$343K Hold
2,262
0.15% 53
2020
Q3
$306K Sell
2,262
-15
-0.7% -$2.04K 0.16% 51
2020
Q2
$311K Hold
2,277
0.17% 47
2020
Q1
$245K Sell
2,277
-84
-4% -$9.67K 0.17% 51
2019
Q4
$285K Sell
2,361
-82
-3% -$9.15K 0.16% 50
2019
Q3
$243K Buy
2,443
+22
+0.9% +$2.3K 0.15% 55
2019
Q2
$264K Hold
2,421
0.17% 53
2019
Q1
$271K Hold
2,421
0.19% 52
2018
Q4
$233K Buy
+2,421
New +$257K 0.19% 52

Other funds holding IBB

Financial Advisors's IBB Position: Q3 2025 in Review

Financial Advisors held its iShares Biotechnology ETF (IBB) position steady in Q3 2025 at 1,667 shares worth $241K. The position accounts for 0.04% of the portfolio, ranked #75.

Financial Advisors first reported a position in IBB in Q4 2018 and has held it in 28 quarters since. The position peaked at $370K in Q2 2021. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Financial Advisors held 1,667 shares of iShares Biotechnology ETF worth $241K as of Q3 2025.
  • Financial Advisors left its iShares Biotechnology ETF share count unchanged in Q3 2025.
  • iShares Biotechnology ETF made up 0.04% of Financial Advisors's portfolio in Q3 2025, its #75 holding.
  • Financial Advisors first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 28 quarters since.
  • Financial Advisors's iShares Biotechnology ETF position peaked at $370K in Q2 2021.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Financial Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.